buserelin has been researched along with Adhesions, Tissue in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Furui, T; Imai, A; Sugiyama, M; Takahashi, S; Tamaya, T | 1 |
Doesburg, WH; Franssen, AM; Rolland, R; Thomas, CM; van der Heijden, PF; Willemsen, WN | 1 |
2 trial(s) available for buserelin and Adhesions, Tissue
Article | Year |
---|---|
Gonadotrophin-releasing hormones agonist therapy increases peritoneal fibrinolytic activity and prevents adhesion formation after myomectomy.
Topics: Adult; Buserelin; Female; Humans; Infertility, Female; Peritoneal Diseases; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Postoperative Complications; Premedication; Prospective Studies; Second-Look Surgery; Severity of Illness Index; Tissue Adhesions; Treatment Outcome | 2003 |
On the origin and significance of serum CA-125 concentrations in 97 patients with endometriosis before, during, and after buserelin acetate, nafarelin, or danazol.
Topics: Antigens, Tumor-Associated, Carbohydrate; Buserelin; Danazol; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Menstrual Cycle; Nafarelin; Osmolar Concentration; Retrospective Studies; Tissue Adhesions | 1992 |